REAL-WORLD OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA (PSCC) RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICI)

被引:2
|
作者
Zhuang, Tony [1 ]
Goyal, Subir [1 ]
Brown, Jacqueline [1 ]
Carthon, Bradley [1 ]
Kucuk, Omer [1 ]
McClintock, Greta [1 ]
Yantorni, Lauren [1 ]
Bilen, Mehmet [1 ]
Master, Viraj [1 ]
Nazha, Bassel [1 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA USA
关键词
D O I
10.1136/jitc-2022-SITC2022.0478
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
478
引用
收藏
页码:A498 / A499
页数:2
相关论文
共 50 条
  • [21] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [22] Neoadjuvant platinum-based chemotherapy (NAPC) for metastatic penile squamous cell carcinoma (PSCC): An international, multicenter, real-world study
    Chahoud, J.
    Mustasam, A.
    Rose, K. M.
    Spiess, P. E.
    Moses, K. L.
    Master, V. A.
    Nazha, B.
    Zhuang, T. Z.
    Schneider, A.
    Marchetti, K.
    Roussel, E.
    Pham, R. T.
    Zacharias, N.
    Pagliaro, L.
    Hernandez, C.
    Montrose, J.
    Alifrangis, C.
    Albersen, M.
    Protzel, C.
    Pettaway, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1143 - S1143
  • [23] A real-world analysis of immune checkpoint inhibitors outcomes in patients with baseline auto-immune diseases
    Omar, N. E.
    Elewa, H.
    Saad, M. O.
    Elkhatim, M. Sir
    Alnajjar, A. R.
    Gulied, A.
    Sahal, A.
    Asmar, A.
    Gebril, F. E.
    Afifi, H. M.
    Benkhadra, M.
    Dawoud, R.
    Elazzazy, S.
    Hamad, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1610 - S1610
  • [24] Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Muniz, Thiago P.
    Fournier, Cynthia
    Abdulalem, Khaled
    Saldanha, Erick F.
    Martinez, Erika
    Spreafico, Anna
    Hogg, David H.
    Butler, Marcus O.
    Saibil, Samuel D.
    CANCERS, 2023, 15 (17)
  • [25] Real-World Survival Outcomes with Immune Checkpoint Inhibitors in Large Cell Neuroendocrine Tumors of Lung
    Dudnik, E.
    Kareff, S.
    Moskovitz, M.
    Lobachov, A.
    Kim, C.
    Liu, S.
    Sherman, S.
    Urban, D.
    Zer, A.
    Rotem, O.
    Wollner, M.
    Bar, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S513 - S513
  • [26] REAL WORLD DATA OF SEQUENCING IMMUNE CHECKPOINT INHIBITORS (ICI) AFTER INITIAL ICI
    Gunturu, Krishna
    Awidi, Muhammad
    Ranjit, Rojer
    Connell, Brendan
    Carrasquillo, Rachel
    Gil, Brigitte
    Dalbo, Natalie
    Maher, Lewena
    Reilly, Seanna
    McDonald, Stephanie
    Tsoukas, Philip
    Voner, Linda
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A174 - A174
  • [27] Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database
    Fan, Qianqian
    Chen, Huan
    Hu, Yang
    Zhao, Bin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2023, 42 (02) : 68 - 73
  • [28] Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Zheng, Ying
    Kim, Ruth
    Yu, Ting
    Gayle, Julie A.
    Wassel, Christina L.
    Dreyfus, Jill
    Phatak, Hemant
    George, Saby
    ONCOLOGIST, 2021, 26 (11): : E2002 - E2012
  • [29] Real-world prevalence of autoimmune disease (AD) among patients (pts) receiving immune checkpoint inhibitors (ICI) in ASCO's CancerLinQ database.
    Chen, Li
    Walker, Mark S.
    Zhi, Jizu
    Komatsoulis, George Anthony
    Jun, Monika
    Stepanski, Edward
    Fukushima, Ryan
    Lau, Denise
    Roberts, Jeremy
    Hyde, Brigham
    Miller, Robert S.
    Khozin, Sean
    Rubinstein, Wendy S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors
    Bonnefin, C.
    Schneider, S.
    Gerard, E.
    Dutriaux, C.
    Ferte, T.
    Prey, S.
    Guicheney, M.
    Ducharme, O.
    Pedeboscq, S.
    Beylot-Barry, M.
    Pham-Ledard, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 217